Efficiency of coenzyme Q10 at experimental spinal cord injury;Deneysel spinal kord yaralanmasinda koenzim Q10'un etkinliǧi

Ulusal Travma ve Acil Cerrahi Dergisi

Volumn 13, Issue 2, 2007, Pages 83-93

  Kerimoǧlu, Alaeddin ^a,c   Paşaoǧlu, Özgül ^b   Kanbak, Güngör ^b   Hanci, Volkan ^a   Özdemir, Filiz ^b   Atasoy, Metin Ant ^b  

^a Sarikamis Army District Hospital Turkey   (Turkey)

^b OSMANGAZI UNIVERSITY MEDICAL FACULTY   (Turkey)

^c Nöroşirürji Kliniǧi ^*  (Turkey)

Author keywords

Coenzyme Q10; Methylprednisolone; Rats, Sprague Dawley; Spinal cord injury

Indexed keywords

MALONALDEHYDE; METHYLPREDNISOLONE; SUPEROXIDE DISMUTASE; UBIDECARENONE; ANTIINFLAMMATORY AGENT; UBIQUINONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COMBINATION CHEMOTHERAPY; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG EFFICACY; HISTOPATHOLOGY; MALE; MONOTHERAPY; NONHUMAN; RAT; SPINAL CORD INJURY; TREATMENT OUTCOME; ANIMAL; DISEASE MODEL; DRUG COMBINATION; EDEMA; INJURY SCALE; INTRAPERITONEAL DRUG ADMINISTRATION; METABOLISM; PATHOLOGY; SPRAGUE DAWLEY RAT; VERTEBRA;

ANIMALS; ANTI-INFLAMMATORY AGENTS; DISEASE MODELS, ANIMAL; DRUG THERAPY, COMBINATION; EDEMA; INJECTIONS, INTRAPERITONEAL; INJURY SEVERITY SCORE; MALE; METHYLPREDNISOLONE; RATS; RATS, SPRAGUE-DAWLEY; SPINAL CORD INJURIES; SUPEROXIDE DISMUTASE; THORACIC VERTEBRAE; UBIQUINONE;

EID: 34247151734     PISSN: 1306696X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Hall ED, Springer JE. Neuroprotection and acute spinal cord injury: a reappraisal. NeuroRx 2004;1:80-100.
2. Folkers K, Langsjoen P, Willis R, Richardson P, Xia LJ, Ye CQ, et al. Lovastatin decreases coenzyme Q levels in humans. Proc Natl Acad Sci 1990;87:8931-4.
3. 10 in hepatic ischemia/reperfusion injury. Clin Biochem 1999;32:461-6.
4. Ostrowski RP. Effect of coenzyme Q10 (CoQ10) on superoxide dismutase activity in ET-1 and ET-3 experimental models of cerebral ischemia in the rat. Folia Neuropathol 1999;37:247-51.
5. Ostrowski RP. Effect of coenzyme Q(10) on biochemical and morphological changes in experimental ischemia in the rat brain. Brain Res Bull 2000;53:399-407.
6. Tator CH. Patophysiology and pathology of spinal cord injury. In: Wilkins RH, Rengachary SS, editors. Spinal trauma. Vol IIB, 2nd ed. New York: Mc.Graw-Hill Inc; 1999. p. 2847-56.
7. Wang R, Ehara K, Tamaki N. Spinal cord edema following freezing injury in the rat: relationship between tissue water content and spinal cord blood flow. Surg Neurol 1993;39:348-54.
8. Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 1979;95:351-8.
9. Winterbourn CC, Hawkins RE, Brian M, Carrell RW. The estimation of red cell superoxide dismutase activity. J Lab Clin Med 1975;85:337-41.
10. Tator CH. Acute management of spinal cord injury. Br J Surg 1990;77:485-6.
11. Tator CH, Edmonds VE. Acute spinal cord injury: analysis of epidemiologic factors. Can J Surg 1979;22:575-8.
12. Tator CH. Review of experimental spinal cord injury with emphasis on the local and systemic circulatory effects. Neurochirurgie 1991;37:291-302.
13. Tator CH, Fehlings MG. Review of the secondary injury theory of acute spinal cord trauma with emphasis on vascular mechanisms. J Neurosurg 1991;75:15-26.
14. Kerimoǧlu M, Hanci V, Kerimoǧlu A. Spinal hasarlanmalar. İkincil hücresel hasar fizyopatolojisi ve tedaviye etkisi. Sendrom 2006;18:26-32.
15. Ducker TB, Zeidman SM. Spinal cord injury. Role of steroid therapy. Spine 1994;19:2281-7.
16. Faden AI. Therapeutic approaches to spinal cord injury. Adv Neurol 1997;72:377-86.
17. Young W. Molecular mechanisms of spinal cord injury therapies. In: Kalb RG, Strimatter SM, editors. Neurobiolgy of spinal cord injury. Totowa: Humana Pres; 2000. p. 241-76.
18. Braughler JM. Lipid peroxidation-induced inhibition of gamma-aminobutyric acid uptake in rat brain synaptosomes: protection by glucocorticoids. J Neurochem 1985;44:1282-8.
19. Taoka Y, Okajima K. Spinal cord injury in the rat. Prog Neurobiol 1998;56:341-58.
20. Bracken MB, Shepard MJ, Collins WF, Holford TR, Young W, Baskin DS, et al. A randomized, controlled trial of methylprednisolone or naloxone in the treatment of acute spinal-cord injury. Results of the Second National Acute Spinal Cord Injury Study. N Engl J Med 1990;322:1405-11.
21. Hall ED, Braughler JM. Glucocorticoid mechanisms in acute spinal cord injury: a review and therapeutic rationale. Surg Neurol 1982;18:320-7.
22. Solaroglu I, Kaptanoglu E, Okutan O, Beskonakli E, Attar A, Kilinc K. Magnesium sulfate treatment decreases caspase-3 activity after experimental spinal cord injury in rats. Surg Neurol. 2005;64 Suppl 2:S17-21.
23. Teng YD, Choi H, Onario RC, Zhu S, Desilets FC, Lan S, et al. Minocycline inhibits contusion-triggered mitochondrial cytochrome c release and mitigates functional deficits after spinal cord injury. Proc Natl Acad Sci 2004;101:3071-6.
24. Erman T, Yildiz MS, Gocer AI, Zorludemir S, Demirhindi H, Tuna M. Effects of antithrombin III on myeloperoxidase activity, superoxide dismutase activity, and malondialdehyde levels and histopathological findings after spinal cord injury in the rat. Neurosurgery 2005;56:828-35.
25. Kaptanoglu E, Solaroglu I, Okutan O, Surucu HS, Akbiyik F, Beskonakli E. Erythropoietin exerts neuroprotection after acute spinal cord injury in rats: effect on lipid peroxidation and early ultrastructural findings. Neurosurg Rev 2004;27:113-20.
26. Gaviria M, Privat A, d'Arbigny P, Kamenka J, Haton H, Ohanna F. Neuroprotective effects of a novel NMDA antagonist, Gacyclidine, after experimental contusive spinal cord injury in adult rats. Brain Res 2000;874:200-9.
27. Wada S, Yone K, Ishidou Y, Nagamine T, Nakahara S, Niiyama T, et al. Apoptosis following spinal cord injury in rats and preventative effect of N-methyl-D-aspartate receptor antagonist. J Neurosurg 1999;91(1 Suppl):98-104.
28. Li S, Tator CH. Effects of MK801 on evoked potentials, spinal cord blood flow and cord edema in acute spinal cord injury in rats. Spinal Cord 1999;37:820-32.
29. Saunders RD, Dugan LL, Demediuk P, Means ED, Horrocks LA, Anderson DK. Effects of methylprednisolone and the combination of alpha-tocopherol and selenium on arachidonic acid metabolism and lipid peroxidation in traumatized spinal cord tissue. J Neurochem 1987;49:24-31.
30. Daneyemez M. Silicone rubber microangiography of injured acute spinal cord after treatment with methylprednisolone and vitamin E in rats. Spine 1999;24:2201-5.
31. Mellors A, Tappel AL. The inhibition of mitochondrial peroxidation by ubiquinone and ubiquinol. J Biol Chem 1966;241:4353-6.
32. Takayanagi R, Takeshige K, Minakami S. NADH- and NADPH-dependent lipid peroxidation in bovine heart submitochondrial particles. Dependence on the rate of electron flow in the respiratory chain and an antioxidant role of ubiquinol. Biochem J 1980;192:853-60.
33. Lemke M, Frei B, Ames BN, Faden AI. Decreases in tissue levels of ubiquinol-9 and -10, ascorbate and alpha-tocopherol following spinal cord impact trauma in rats. Neurosci Lett 1990;108:201-6.
34. Yoshida S, Abe K, Busto R, Watson BD, Kogure K, Ginsberg MD. Influence of transient ischemia on lipid-soluble antioxidants, free fatty acids and energy metabolites in rat brain. Brain Res 1982;245:307-16.
35. Shults CW, Haas RH, Passov D, Beal MF. Coenzyme Q10 levels correlate with the activities of complexes I and II/III in mitochondria from parkinsonian and nonparkinsonian subjects. Ann Neurol 1997;42:261-4.
36. Beal MF, Matthews RT, Tieleman A, Shults CW. Coenzyme Q10 attenuates the 1-methyl-4-phenyl-1,2,3,tetrahydropyridine (MPTP) induced loss of striatal dopamine and dopaminergic axons in aged mice. Brain Res 1998;783:109-14.
37. Piotrowski P, Ostrowski RP, Pankowska T, Smialek M. The effect of coenzyme Q10 on lactate acidosis at the beginning of experimental cerebral ischemia in rats after the use of endothelin 1 (preliminary results). [Article in Polish] Neurol Neurochir Pol 1998;32:1397-404. [Abstract]
38. Koroshetz WJ, Jenkins BG, Rosen BR, Beal MF. Energy metabolism defects in Huntington's disease and effects of coenzyme Q10. Ann Neurol 1997;41:160-5.
39. Beal MF, Henshaw DR, Jenkins BG, Rosen BR, Schulz JB. Coenzyme Q10 and nicotinamide block striatal lesions produced by the mitochondrial toxin malonate. Ann Neurol 1994;36:882-8.
40. Bracken MB, Collins WF, Freeman DF, Shepard MJ, Wagner FW, Silten RM, et al. Efficacy of methylprednisolone in acute spinal cord injury. JAMA 1984;251:45-52.
41. Bracken MB, Shepard MJ, Collins WF Jr, Holford TR, Baskin DS, Eisenberg HM, et al. Methylprednisolone or naloxone treatment after acute spinal cord injury: 1-year follow-up data. Results of the second National Acute Spinal Cord Injury Study. J Neurosurg 1992;76:23-31.
42. Bracken MB, Shepard MJ, Holford TR, Leo-Summers L, Aldrich EF, Fazl M, et al. Administration of methylprednisolone for 24 or 48 hours or tirilazad mesylate for 48 hours in the treatment of acute spinal cord injury. Results of the Third National Acute Spinal Cord Injury Randomized Controlled Trial. National Acute Spinal Cord Injury Study. JAMA 1997;277:1597-604.
43. Bracken MB, Shepard MJ, Holford TR, Leo-Summers L, Aldrich EF, Fazl M, et al. Methylprednisolone or tirilazad mesylate administration after acute spinal cord injury: 1-year follow up. Results of the third National Acute Spinal Cord Injury randomized controlled trial. J Neurosurg 1998;89:699-706.
44. Bhagavan HN, Chopra RK. Coenzyme Q10: absorption, tissue uptake, metabolism and pharmacokinetics. Free Radic Res 2006;40:445-53.
45. Yokoyama K, Nakamura K, Nakamura K, Kimura M, Nomoto K, Itoman M. Effect of coenzyme Q10 on superoxide production in rats with reperfusion injuries. Scand J Plast Reconstr Surg Hand Surg 1999;33:1-5.
46. Yokoyama K, Itoman M, Takagishi K, Yamamoto M. Protective effects of coenzyme Q10 on ischemia-induced reperfusion injury in ischemic limb models. Plast Reconstr Surg 1992;90:890-8.
47. Li H, Klein G, Sun P, Buchan AM. CoQ10 fails to protect brain against focal and global ischemia in rats. Brain Res 2000;877:7-11.